Clinical Trial

Imaging of Brain Function

Study Description

Use of 31P MRS to Assess Brain NAD+ in Healthy Current and Former Collegiate Athletes

Can nicotinamide riboside (750 mg/day for 12 weeks) affect the levels of NAD+ in the brain as measured by 31P MRS?

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Dietary Supplement - Nicotinamide Riboside

Three capsules, twice per day for 84 days

Matching placebo

Three matching capsules, twice per day for 84 days

Additional Information

Official Study Title

Use of 31P MRS to Assess Brain NAD+ in Healthy Current and Former Collegiate Athletes and a Comparison of the Effect of Nicotinamide Riboside Supplementation on Brain NAD+ Levels

Clinical Trial ID

NCT02721537

ParticipAid ID

BeXVVb